EPL Limited (NSE:EPL)

Oncternal Therapeutics Revenue

In the fiscal year ending March 31, 2025, EPL Limited had annual revenue of 42.13B INR with 7.59% growth. EPL Limited had revenue of 11.05B in the quarter ending March 31, 2025, with 7.40% growth.

• Revenue: 42.13B
• Revenue Growth: +7.59%
• P/S Ratio: 1.71
• Revenue / Employee: 29.53M
• Employees: 1,427
• Market Cap: 72.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	42.13B	2.97B	7.59%
Mar 31, 2024	39.16B	2.22B	6.01%
Mar 31, 2023	36.94B	2.61B	7.61%
Mar 31, 2022	34.33B	3.41B	11.04%
Mar 31, 2021	30.92B	3.30B	11.96%